(COTY) Coty - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2220702037

COTY: Fragrances, Cosmetics, Skincare

Coty Inc. (NYSE:COTY) is a global beauty products manufacturer, marketer, and distributor operating through two primary segments: Prestige and Consumer Beauty. The company specializes in fragrances, color cosmetics, and skin and body care products. Its Prestige segment caters to luxury markets, offering high-end products under brands like Burberry, Calvin Klein, Chloe, Gucci, Hugo Boss, and Tiffany & Co., distributed through prestige retailers, e-retailers, and duty-free shops. The Consumer Beauty segment targets mass markets with brands such as Adidas, Beckham, CoverGirl, Max Factor, Rimmel, and Sally Hansen, sold through hypermarkets, pharmacies, and e-commerce platforms. Coty also utilizes third-party distributors to expand its reach. Founded in 1904 and headquartered in New York, Coty is a subsidiary of JAB Beauty B.V.

Technically, COTY is trading below its 20-day and 50-day moving averages but above its 200-day moving average, signaling potential bearish momentum in the short term. The average trading volume over 20 days is 8,364,400 shares, with a last price of $4.97. The stocks ATR of 0.25 indicates low volatility. From a fundamental perspective, Coty has a market cap of $4.14 billion, a forward P/E of 9.43, and a P/B ratio of 1.20, suggesting moderate valuation metrics. The P/S ratio of 0.68 reflects lower revenue per share, while the RoE of 0.27 points to limited profitability.

3-Month Forecast: Based on the provided data, Cotys stock is expected to experience increased volatility as it trades below its 20-day and 50-day SMAs, potentially leading to bearish price action. The low ATR of 0.25 suggests that price swings will remain moderate. The forward P/E of 9.43 may attract value investors, but the low ROE and P/S ratio indicate limited upside potential. Overall, the outlook is neutral with a slight bearish bias, driven by technical indicators and fundamental valuation metrics.

Additional Sources for COTY Stock

COTY Stock Overview

Market Cap in USD 4,499m
Sector Consumer Defensive
Industry Household & Personal Products
GiC Sub-Industry Personal Care Products
IPO / Inception 2013-06-13

COTY Stock Ratings

Growth Rating -7.81
Fundamental 13.6
Dividend Rating 12.8
Rel. Strength -60
Analysts 3.82/5
Fair Price Momentum 3.55 USD
Fair Price DCF 7.22 USD

COTY Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 51.3%

COTY Growth Ratios

Growth Correlation 3m -86.6%
Growth Correlation 12m -97.4%
Growth Correlation 5y 38.3%
CAGR 5y 0.17%
CAGR/Max DD 5y 0.00
Sharpe Ratio 12m -1.58
Alpha -63.72
Beta 0.587
Volatility 66.82%
Current Volume 11128.7k
Average Volume 20d 7611.2k
What is the price of COTY stocks?
As of May 09, 2025, the stock is trading at USD 4.82 with a total of 11,128,708 shares traded.
Over the past week, the price has changed by -3.98%, over one month by +2.77%, over three months by -28.80% and over the past year by -55.74%.
Is Coty a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Coty is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.58 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COTY as of May 2025 is 3.55. This means that COTY is currently overvalued and has a potential downside of -26.35%.
Is COTY a buy, sell or hold?
Coty has received a consensus analysts rating of 3.82. Therefor, it is recommend to buy COTY.
  • Strong Buy: 9
  • Buy: 2
  • Hold: 9
  • Sell: 2
  • Strong Sell: 0
What are the forecast for COTY stock price target?
According to ValueRays Forecast Model, COTY Coty will be worth about 3.8 in May 2026. The stock is currently trading at 4.82. This means that the stock has a potential downside of -20.54%.
Issuer Forecast Upside
Wallstreet Target Price 7.4 54.1%
Analysts Target Price 7.2 50.2%
ValueRay Target Price 3.8 -20.5%